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We read with interest the article by Solak et al entitled ''Impact of Elevated Serum Uric Acid Levels on Systemic Inflammation in Patients With Psoriasis.'' 1 They found that the neutrophil to lymphocyte ratio (NLR) and C-reactive protein are independent predictors of Psoriasis Area and Severity Index score.
Inflammation is an important factor in the pathogenesis of several diseases such as coronary artery disease, diabetes mellitus, hypertension, obesity, hyperlipidemia, and psoriasis. 2, 3 Psoriasis is a chronic inflammatory skin disease that affects approximately 2% to 3% of the general population. 4 It has been shown that psoriasis is associated with an increased cardiovascular (CV) risk. 5 Patients with psoriasis are more susceptible to several CV risk factors (hypertension, obesity, dyslipidemia, and smoking), noncardiac vascular diseases (peripheral artery disease and chronic kidney disease), and metabolic comorbidities (diabetes mellitus, metabolic syndrome, and obstructive sleep apnea) compared with the general population. 6 Previous studies showed that the presence of severe psoriasis was related to approximately 60% increased risk of CV mortality 7 and that CV risk was especially high in younger patients (age <60 years) with severe disease (patients with a diagnostic code of psoriasis and history of systemic therapy consistent with severe psoriasis). 7, 8 The NLR is a ratio of 2 different supplementary immune pathways, thus integrating the detrimental effects of neutrophils, which are responsible for active nonspecific inflammation and lymphopenia, which is a marker of poor general heath and physiological stress. 9 Furthermore, the NLR was independently associated with adverse CV outcomes. 10 The authors 1 excluded patients on corticosteroids, thiazide-type diuretics, or allopurinol and those with active infection or overt cancer. However, they did not mention any information about patients with CV disease that increases the NLR (eg, severe valvular heart disease, coronary artery disease, heart failure, and peripheral artery disease).
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Is there any correlation between the disease duration and NLR or serum uric acid levels? The evidence that disease duration affects the inflammation burden of psoriasis is contradictory. Eder et al did not show any association between disease duration and atherosclerosis in patients with psoriasis. 11 In contrast, Shaharyar et al found a relationship between disease duration and subclinical atherosclerotic markers. 12 
